Generation Bio

Generation Bio company information, Employees & Contact Information

Explore related pages

Related company profiles:

Generation Bio is a biotechnology company changing what is possible for people living with T cell-driven autoimmune diseases. The company is developing a new modality of therapeutics leveraging its T cell selective cell-targeted lipid nanoparticle (ctLNP) to deliver siRNA in vivo, enabling modulation of T cell activity that causes inflammation and auto-reactive tissue destruction.

Company Details

Employees
121
Founded
-
Address
301 Binney Street,
Email
in****@****bio.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Cambridge, Massachusetts
Looking for a particular Generation Bio employee's phone or email?

Generation Bio Questions

News

Generation Bio CEO Geoff McDonough, MD to Step Down - citybiz

Generation Bio CEO Geoff McDonough, MD to Step Down citybiz

Geoff McDonough Steps Down as CEO of Generation Bio, Yalonda Howze Appointed Interim CEO - Quiver Quantitative

Geoff McDonough Steps Down as CEO of Generation Bio, Yalonda Howze Appointed Interim CEO Quiver Quantitative

Generation Bio (NASDAQ: GBIO) names Howze interim CEO; McDonough to chair board - Stock Titan

Generation Bio (NASDAQ: GBIO) names Howze interim CEO; McDonough to chair board Stock Titan

Generation Bio Announces 1-for-10 Reverse Stock Split - Yahoo Finance

Generation Bio Announces 1-for-10 Reverse Stock Split Yahoo Finance

Generation jettisons 90% of employees due to lack of time, cash to develop autoimmune tech - Fierce Biotech

Generation jettisons 90% of employees due to lack of time, cash to develop autoimmune tech Fierce Biotech

Generation Bio Co. Advances T Cell-Selective siRNA Therapeutics for Autoimmune Diseases, Announces Robust Financial Position - Nasdaq

Generation Bio Co. Advances T Cell-Selective siRNA Therapeutics for Autoimmune Diseases, Announces Robust Financial Position Nasdaq

Generation Bio Boots 90% of Staff Amid Dwindling Cash Reserves - BioSpace

Generation Bio Boots 90% of Staff Amid Dwindling Cash Reserves BioSpace

Generation Bio's T Cell Delivery Success Leads to Strategic Review as Company Cuts 90% of Workforce - Stock Titan

Generation Bio's T Cell Delivery Success Leads to Strategic Review as Company Cuts 90% of Workforce Stock Titan

Generation Bio Grants $41K Worth of Stock Options Under New Incentive Plan - Stock Titan

Generation Bio Grants $41K Worth of Stock Options Under New Incentive Plan Stock Titan

Generation Bio Announces the Presentation of Preclinical - GlobeNewswire

Generation Bio Announces the Presentation of Preclinical GlobeNewswire

Generation Bio Plans 1-for-10 Reverse Split: What This Means for 67.3M Shares and Nasdaq Status - Stock Titan

Generation Bio Plans 1-for-10 Reverse Split: What This Means for 67.3M Shares and Nasdaq Status Stock Titan

The Global Nanomedicine Market: Key Players and Emerging Technologies in Healthcare - AZoNano

The Global Nanomedicine Market: Key Players and Emerging Technologies in Healthcare AZoNano

Generation Bio Announces Demonstration of Highly Selective - GlobeNewswire

Generation Bio Announces Demonstration of Highly Selective GlobeNewswire

Generation Bio Names Phillip Samayoa, Ph.D. as Chief Strategy Officer - citybiz

Generation Bio Names Phillip Samayoa, Ph.D. as Chief Strategy Officer citybiz

Generation Bio (GBIO) Stock Price, News & Analysis - MarketBeat

Generation Bio (GBIO) Stock Price, News & Analysis MarketBeat

GBIO Stock Price and Chart — NASDAQ:GBIO - TradingView

GBIO Stock Price and Chart — NASDAQ:GBIO TradingView

Top Generation Bio Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant